{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:11Z","timestamp":1790831411882,"version":"4.1.0"},"reference-count":116,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Despite numerous studies evaluating the risk of breast cancer among oral contraception users, the effect of oral contraceptive on developing breast cancer remains inconclusive. Therefore, we conducted a systematic review of literature with meta-analysis in order to quantitative estimate this association. The bibliographic database MEDLINE and EMBASE, and reference lists of identified articles were searched, with no language restrictions, from the start of publication to August 2010. We performed a reanalysis and overall estimate of 79 case-control studies conducted between 1960\u20132010, including a total of 72,030 incidents, histologically confirmed cases of breast cancer and 123,650 population\/hospital controls. A decrease was observed in cancer risk in OC users before age 25 years (0.91, 0.83\u20131.00). However, the use of OCs before the first full-term pregnancy had a significant increased risk of breast cancer (OR, 1.14, 1.01\u20131.28, p = 0.04), as did OC use longer than 5 years (1.09, 1.01\u20131.18, p = 0.02). Pooled crude odds ratios of breast cancer in ever-users of oral contraceptives was 1.01 [95% confidence interval (CI), 0.95\u20131.07], compared with never-users. There was no significant increase in risk among premenopausal women (1.06, 0.92\u20131.22), postmenopausal women (0.99, 0.89\u20131.10), or nulliparous women (1.02, 0.82\u20131.26). Oral contraceptives do not appear to increase the risk of breast cancer among users. However, OC use before a first full-term pregnancy or using them longer than 5 years can modify the development of the breast cancer.<\/jats:p>","DOI":"10.3390\/ijerph18094638","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T21:18:20Z","timestamp":1619558300000},"page":"4638","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010"],"prefix":"10.3390","volume":"18","author":[{"given":"Wies\u0142aw","family":"Kanadys","sequence":"first","affiliation":[{"name":"Specialistic Medical Center \u201cCzech\u00f3w\u201d in Lublin, 20-848 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-0184","authenticated-orcid":false,"given":"Agnieszka","family":"Bara\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Statistics with E-learning Lab, Medical University, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-926X","authenticated-orcid":false,"given":"Maria","family":"Malm","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Statistics with E-learning Lab, Medical University, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"B\u0142aszczuk","sequence":"additional","affiliation":[{"name":"Department of Virology with SARS Laboratory, Medical University, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Polz-Dacewicz","sequence":"additional","affiliation":[{"name":"Department of Virology with SARS Laboratory, Medical University, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-6783","authenticated-orcid":false,"given":"Mariola","family":"Janiszewska","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Statistics with E-learning Lab, Medical University, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-9583","authenticated-orcid":false,"given":"Marian","family":"J\u0119drych","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Statistics with E-learning Lab, Medical University, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"Breast cancer-epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ije\/dyh414","article-title":"Global trends in breast cancer incidence and mortality 1973\u20131997","volume":"34","author":"Althuis","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/annonc\/mdm593","article-title":"Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations","volume":"19","author":"Ferlay","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","article-title":"Breast cancer incidence, 1980\u20132006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status","volume":"99","author":"Glass","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.maturitas.2009.07.015","article-title":"The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence","volume":"64","author":"Verkooijen","year":"2009","journal-title":"Maturitas"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women\u2019s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4065\/83.1.86","article-title":"Oral contraceptive use and risk of breast cancer","volume":"83","author":"Casey","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/cncr.25679","article-title":"Update on mammography trends: Comparisons of rates in 2000, 2005, and 2008","volume":"117","author":"Breen","year":"2011","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7861\/clinmedicine.5-5-491","article-title":"Genetic predisposition to cancer","volume":"5","author":"Turnbull","year":"2005","journal-title":"Clin. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"97","author":"Kaaks","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1677\/erc.1.01038","article-title":"Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition","volume":"12","author":"Kaaks","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625180903427675","article-title":"Efficacy of contraceptive methods: A review of the literature","volume":"15","author":"Mansour","year":"2010","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"ref_15","unstructured":"(2007). IARC Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr. Eval. Carcinog. Risks Hum., 91, 1\u2013528."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"Cibula","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4065\/83.7.849-a","article-title":"Oral contraceptives and breast cancer","volume":"83","author":"Kahlenborn","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_18","first-page":"123","article-title":"Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports","volume":"6","author":"Hawley","year":"1993","journal-title":"J. Am. Board Fam. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1471-0528.1992.tb14506.x","article-title":"Oral contraceptive use and breast cancer risk: A meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use","volume":"99","author":"Rushton","year":"1992","journal-title":"Br. J. Obs. Gynaecol."},{"key":"ref_20","first-page":"165","article-title":"Oral contraceptives and breast cancer. A meta-analysis","volume":"39","year":"1991","journal-title":"Rev. Epidemiol. Sante Publique"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996). Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713\u20131727.","DOI":"10.1016\/S0140-6736(96)90806-5"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2105\/AJPH.81.1.90","article-title":"Trends in the content and use of oral contraceptives in the United States, 1964\u20131988","volume":"81","author":"Gerstman","year":"1991","journal-title":"Am. J. Public Health"},{"key":"ref_24","first-page":"4","article-title":"Trends in oral contraceptive development and utilization: Looking to the future","volume":"7","author":"Westhoff","year":"1997","journal-title":"Contracept. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2002-24241","article-title":"Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit","volume":"124","author":"Heinemann","year":"2002","journal-title":"Zent. Gynakol"},{"key":"ref_26","first-page":"11","article-title":"Trends in use of oral contraceptives in Britain","volume":"16","author":"Thorogood","year":"1990","journal-title":"Brit. J. Fam. Plan."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/72.1.39","article-title":"A case-control study of oral contraceptive use and breast cancer","volume":"72","author":"Hennekens","year":"1984","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.1983.74","article-title":"Oral contraceptives and breast cancer: Final report of an epidemiological study","volume":"47","author":"Vessey","year":"1983","journal-title":"Br. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/1097-0142(197806)41:6<2341::AID-CNCR2820410637>3.0.CO;2-N","article-title":"The epidemiology of breast cancer in 785 United States Caucasian women","volume":"41","author":"Wynder","year":"1978","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/jnci\/59.6.1589","article-title":"Exogenous hormones, reproductive history, and breast cancer","volume":"59","author":"Sartwell","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/oxfordjournals.aje.a112992","article-title":"Characteristics that predict risk of breast cancer before and after the menopause","volume":"112","author":"Paffenbarger","year":"1980","journal-title":"Am. J. Epidemiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ijc.2910220611","article-title":"Oral contraceptives and breast disease in premenopausal northern Albertan women","volume":"22","author":"Lees","year":"1978","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0014-2964(79)90074-4","article-title":"An epidemiologic study of breast cancer and benign breast neoplasia in relation to the oral contraceptive and estrogen use","volume":"15","author":"Ravnihar","year":"1979","journal-title":"Eur. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/bjc.1981.10","article-title":"Oral contraceptive use and early abortion as risk factors for breast cancer in young women","volume":"43","author":"Pike","year":"1981","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/bjc.1989.288","article-title":"Oral contraceptives and breast cancer: Results from an expanded case-control study","volume":"60","author":"Stanford","year":"1989","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0021-9681(83)90080-2","article-title":"Breast cancer and oral contraceptive use: A case-control study","volume":"36","author":"Janerich","year":"1983","journal-title":"J. Chronic Dis."},{"key":"ref_41","first-page":"211","article-title":"Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis","volume":"68","author":"Lubin","year":"1982","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_42","first-page":"395","article-title":"Oral contraceptives and breast cancer: A case-control study with hospital and community controls","volume":"76","author":"Schildkraut","year":"1990","journal-title":"Obs. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.aje.a113447","article-title":"Breast cancer in relation to patterns of oral contraceptive use","volume":"116","author":"Harris","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.aje.a008654","article-title":"Case-control study of oral contraceptive use and risk of breast cancer","volume":"143","author":"Rosenberg","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00051407","article-title":"Oral contraceptive use and breast cancer risk among African-American women","volume":"6","author":"Palmer","year":"1995","journal-title":"Cancer Causes Control"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ije\/24.2.292","article-title":"A case-control study of risk factors for breast cancer in Brazil, 1978\u20131987","volume":"24","author":"Gomes","year":"1995","journal-title":"Int. J. Epidemiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/bjc.1989.125","article-title":"Oral contraceptives and breast cancer","volume":"59","author":"Jick","year":"1989","journal-title":"Br. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ije\/19.2.240","article-title":"Oral contraceptives and breast cancer risk: A case-control study","volume":"19","author":"Harris","year":"1990","journal-title":"Int. J. Epidemiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/jnci\/81.13.1000","article-title":"Early oral contraceptive use and breast cancer among premenopausal women: Final report from a study in southern Sweden","volume":"81","author":"Olsson","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_50","first-page":"109","article-title":"A case-control study of breast cancer in relation to oral contraceptive use in Slovenia","volume":"35","author":"Ravnihar","year":"1988","journal-title":"Neoplasia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ije\/14.1.70","article-title":"Reproductive and hormonal factors and breast cancer in a Northern Italian population","volume":"14","author":"Talamini","year":"1985","journal-title":"Int. J. Epidemiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.1987.261","article-title":"Early oral contraceptive use and breast cancer: Results of another case-control study","volume":"56","author":"McPherson","year":"1987","journal-title":"Br. J. Cancer"},{"key":"ref_53","first-page":"161","article-title":"Age specific differences in the relationship between oral contraceptive use and breast cancer","volume":"78","author":"Wingo","year":"1991","journal-title":"Obs. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5694\/j.1326-5377.1986.tb128351.x","article-title":"A case-control study of breast cancer in relation to the use of steroid contraceptive agents","volume":"144","author":"Ellery","year":"1986","journal-title":"Med. J. Aust."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"UK National Case-control Study Group (1989). Oral contraceptive use and breast cancer risk in young women. Lancet, 1, 973\u2013982.","DOI":"10.1016\/S0140-6736(89)92627-5"},{"key":"ref_56","first-page":"1247","article-title":"A case-control study of breast cancer and hormonal contraception in Costa Rica","volume":"79","author":"Lee","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5694\/j.1326-5377.1988.tb120759.x","article-title":"Oral contraceptive agents and breast cancer: A population-based case-control study","volume":"149","author":"Rohan","year":"1988","journal-title":"Med. J. Aust."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1990). Breast cancer and combined oral contraceptives: Results from a multinational study. Br. J. Cancer, 61, 110\u2013119.","DOI":"10.1038\/bjc.1990.23"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/oxfordjournals.aje.a116464","article-title":"A case-control study of the risk of breast cancer in relation to oral contraceptive use","volume":"136","author":"Rosenberg","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/bjc.1993.387","article-title":"Oral contraceptives and breast cancer in North Italy. Final report from a case-control study","volume":"68","author":"Tavani","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jnci\/86.7.505","article-title":"Breast cancer among young U.S. women in relation to oral contraceptive use","volume":"86","author":"White","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/0959-8049(92)90481-G","article-title":"Oral contraceptives and breast cancer risk in Denmark","volume":"28A","author":"Ewertz","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/oxfordjournals.aje.a010053","article-title":"Breast cancer and oral contraceptive use in Asian-American women","volume":"150","author":"Ursin","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF00054155","article-title":"Spears GF. Oral contraceptive use and risk of breast cancer in older women (New Zealand)","volume":"6","author":"Paul","year":"1995","journal-title":"Cancer Causes Control"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006037823178","article-title":"Use of oral contraceptives and risk of breast cancer in young women","volume":"50","author":"Ursin","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ije\/20.1.32","article-title":"Oral contraceptives and breast cancer: A French case-control study","volume":"20","author":"Clavel","year":"1991","journal-title":"Int. J. Epidemiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001648-199109000-00007","article-title":"Breast cancer risk and oral contraceptive use: Results from a large case-control study","volume":"2","author":"Weinstein","year":"1991","journal-title":"Epidemiology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/ije\/18.3.527","article-title":"Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: Possible effects of different pattern of use","volume":"18","author":"Lund","year":"1989","journal-title":"Int. J. Epidemiol."},{"key":"ref_69","first-page":"1949","article-title":"Risk factors for breast cancer in Chinese women in Shanghai","volume":"48","author":"Yuan","year":"1988","journal-title":"Cancer Res."},{"key":"ref_70","first-page":"435","article-title":"A case-control study of breast cancer in Tianjin, China","volume":"1","author":"Wang","year":"1992","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00008469-199610000-00004","article-title":"A breast cancer case-control study in Girona, Spain. Endocrine, familial and lifestyle factors","volume":"5","author":"Viladiu","year":"1996","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(94)92826-6","article-title":"Netherlands Oral Contraceptives and Breast Cancer Study Group. Oral contraceptives and risk of breast cancer in women aged 20-54 years","volume":"344","author":"Rookus","year":"1994","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00146884","article-title":"Risk factors for breast cancer by age and menopausal status: A case-control study in Singapore","volume":"3","author":"Lee","year":"1992","journal-title":"Cancer Causes Control"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ijc.2910620410","article-title":"Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54","volume":"62","author":"Evstifeeva","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.aje.a008903","article-title":"Oral contraceptive use and risk of breast cancer in middle-aged women","volume":"144","author":"Rossing","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00051885","article-title":"Recent oral contraceptive use and risk of breast cancer (United States)","volume":"7","author":"Newcomb","year":"1996","journal-title":"Cancer Causes Control"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.2910620510","article-title":"Oral contraceptives, menopausal estrogens, and the risk of breast cancer: A case-control study in Greece","volume":"62","author":"Lipworth","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_78","first-page":"547","article-title":"Breast cancer in relation to some reproductive factors","volume":"74","author":"Kishk","year":"1999","journal-title":"J. Egypt Public Health Assoc."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008469-199608000-00006","article-title":"Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk","volume":"5","author":"Levi","year":"1996","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.bjc.6600691","article-title":"Hormonal content and potency of oral contraceptives and breast cancer risk among young women","volume":"88","author":"Althuis","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0010-7824(93)90041-5","article-title":"Oral contraceptive use and breast cancer in Indonesia","volume":"47","author":"Bustan","year":"1993","journal-title":"Contraception"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ijc.2910600205","article-title":"Oral contraceptives and breast cancer: A cooperative Italian study","volume":"60","author":"Negri","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1008886328352","article-title":"Breast cancer in Australian women under the age of 40","volume":"9","author":"McCredie","year":"1998","journal-title":"Cancer Causes Control"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2168.1999.01117.x","article-title":"Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria","volume":"86","author":"Adebamowo","year":"1999","journal-title":"Br. J. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1749-6632.1996.tb16281.x","article-title":"Oral contraceptive use and breast cancer risk in areas with different incidence: A case-control study among young women","volume":"784","author":"Traina","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/bjc.1997.133","article-title":"A case-control study of breast cancer in Taiwan\u2013a low-incidence area","volume":"75","author":"Yang","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19980717)77:2<219::AID-IJC9>3.0.CO;2-T","article-title":"Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives","volume":"77","author":"Chie","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwh331","article-title":"Comparative analysis of breast cancer risk factors among African-American women and White women","volume":"161","author":"Hall","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1524-4741.2009.00764.x","article-title":"The role of smoking in breast cancer development: An analysis of a Mayo Clinic cohort","volume":"15","author":"Croghan","year":"2009","journal-title":"Breast J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.0.CO;2-R","article-title":"The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years","volume":"80","author":"Magnusson","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kwn360","article-title":"A case-control study of oral contraceptive use and incident breast cancer","volume":"169","author":"Rosenberg","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1440-1622.1999.01655.x","article-title":"Predictors of breast cancer in women recalled following screening","volume":"69","author":"Price","year":"1999","journal-title":"Aust. N. Z. J. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1590\/S0034-89102001000100005","article-title":"Contraceptivos orais e cancer de mama: Estudo de casos e controles","volume":"35","author":"Tessaro","year":"2001","journal-title":"Rev. Sa\u00fade P\u00fablica"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/aje\/kwm006","article-title":"Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk","volume":"165","author":"Shantakumar","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr454","article-title":"Risk factors for breast cancer in Iran: A case-control study","volume":"4","author":"Ebrahimi","year":"2002","journal-title":"Breast Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/02841860214964","article-title":"Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation\u2014a case-control study","volume":"41","author":"Kuru","year":"2002","journal-title":"Acta Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Hadjisavvas, A., Loizidou, M.A., Middleton, N., Michael, T., Papachristoforou, R., Kakouri, E., Daniel, M., Papadopoulos, P., Malas, S., and Marcou, Y. (2010). An investigation of breast cancer risk factors in Cyprus: A case control study. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-447"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sj.bjc.6601916","article-title":"Smoking before the birth of a first child is not associated with increased risk of breast cancer: Findings from the British Women\u2019s Heart and Health Cohort Study and a meta-analysis","volume":"91","author":"Lawlor","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.22970","article-title":"Oral injected implanted contraceptives breast cancer risk among, U.S. Hispanic and non-Hispanic white women","volume":"121","author":"Sweeney","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7819-7-37","article-title":"Breast cancer risk factors in Turkish women\u2014a University Hospital based nested case control study","volume":"7","author":"Ozmen","year":"2009","journal-title":"World J. Surg. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.26719\/2007.13.6.1265","article-title":"Breast cancer risk factors in south of Islamic Republic of Iran: A case-control study","volume":"13","author":"Mahouri","year":"2007","journal-title":"East. Mediterr. Health J."},{"key":"ref_104","first-page":"698","article-title":"Risk factors of breast cancer in women in Kelantan, Malaysia","volume":"46","author":"Rusli","year":"2005","journal-title":"Singap. Med. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2354.2006.00711.x","article-title":"Risk factors for breast cancer in Turkish women: A hospital-based case-control study","volume":"16","author":"Beji","year":"2007","journal-title":"Eur. J. Cancer Care"},{"key":"ref_106","first-page":"51","article-title":"Lifestyle factors and breat cancer: A case-control study in Kuala Lumpur, Malaysia","volume":"7","author":"Kamarudin","year":"2006","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Dinger, J.C., Heinemann, L.A.J., M\u00f6hner, S., Thai, D.M., and Assman, A. (2006). Breast cancer risk associated with different HRT formulations: A register-based case-control study. BMC Women\u2019s Health, 6.","DOI":"10.1186\/1472-6874-6-13"},{"key":"ref_108","first-page":"370","article-title":"Reproductive characteristics and the risk of breast cancer-a case-control study in Iran","volume":"6","author":"Yavari","year":"2005","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_109","first-page":"242","article-title":"Risk factors for breast cancer in patients treated at NORI Hospital, Islamabad","volume":"57","author":"Faheem","year":"2007","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/1097-0142(19901201)66:11<2253::AID-CNCR2820661102>3.0.CO;2-G","article-title":"Oral contraceptives and breast cancer. Review and meta-analysis","volume":"66","author":"Romieu","year":"1990","journal-title":"Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0010-7824(91)90006-2","article-title":"Oral contraceptives and breast cancer: Review of the epidemiologic literature","volume":"43","author":"Thomas","year":"1991","journal-title":"Contraception"},{"key":"ref_112","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996). Breast cancer and hormonal contraceptives: Further results. Contraception, 54, 1S\u2013106S."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral Contraceptives and Breast Cancer Risk in the International BRCA1\/2 Carrier Cohort Study: A Report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1158\/1055-9965.EPI-08-0396","article-title":"Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1\/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study","volume":"17","author":"Lee","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Petitti, D. (2000). Meta-Analysis, Decision, Analysis, and Cost-Effectiveness Analysis, Oxford University Press.","DOI":"10.1093\/acprof:oso\/9780195133646.001.0001"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/9\/4638\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:53:26Z","timestamp":1760162006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/9\/4638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":116,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijerph18094638"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18094638","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}